Calliditas Therapeutics

Calliditas starts Phase II trial for rare kidney disease therapy
Clinical Trials Arena
Thu, 11/30/23 - 10:04 am
Calliditas Therapeutics
clinical trials
Alport syndrome
kidney disease
setanaxib
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics